Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma

13 Nov 2020

Abstract excerpt

Introduction: Tumor mutation burden(TMB) is an emerging biomarker for immunotherapy of hepatocellular carcinoma(HCC), but its value of clinical application has not been fully revealed. Materials and methods: We used wilcox test to identify the differentially expressed immune genes (DEIRGs) in groups with high and low TMB, respectively, as well as screened the immune gene pairs related to prognosis using...

Topics

Join the communities discussing this publication.

Cancer Immunotherapy and Biomarkers
Ferroptosis and cancer prognosis
Hepatocellular Carcinoma Treatment and Prognosis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33282911
DOI: 10.3389/fmolb.2020.581354

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular CarcinomaPMID 33282911Read ↗

A novel panel based on immune infiltration and tumor mutational burden for prognostic prediction in hepatocellular carcinoma.Semantic proximity Read ↗

Development of a Predictive Immune-Related Gene Signature Associated With Hepatocellular Carcinoma Patient Prognosis.Semantic proximity Read ↗

Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinomaSemantic proximity Read ↗

Identification and Analysis of Immune-Related Gene Signature in Hepatocellular CarcinomaSemantic proximity Read ↗

A novel panel based on Immune infiltration and tumor mutational burden for prognostic prediction in hepatocellular carcinomaSemantic proximity Read ↗

Integrative study reveals the prognostic and immunotherapeutic value of CTCs/CTMs -related prognostic signature in Hepatocellular carcinomaSemantic proximity Read ↗

Identification of a seven-gene signature predicting clinical outcome of liver cancer based on tumor mutational burdenSemantic proximity Read ↗

Development and Validation of a Novel Immune-Gene Pairs Prognostic Model Associated with CTNNB1 Alteration in Hepatocellular CarcinomaSemantic proximity Read ↗

Diagnosis and prognosis models for hepatocellular carcinoma patient's management based on tumor mutation burden.Semantic proximity Read ↗

A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltrationSemantic proximity Read ↗

Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomesSemantic proximity Read ↗

Exploration of Key Genes Combining with Immune Infiltration Level and Tumor Mutational Burden in Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.